TSE:TH

Theratechnologies - TH Stock Forecast, Price & News

C$1.34

+0.06 (+4.69%)

(As of 02/3/2023 12:00 AM ET)

Add

Compare

Today's Range: C$1.26
▼
C$1.37
50-Day Range: C$1.13
▼
C$2.93
52-Week Range: C$1.03
▼
C$4.12

Volume: 25,134 shs
Average Volume: 23,229 shs
Market Capitalization: C$127.49 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: C$3.25

Institutional Ownership

Headlines

Social Media

About Theratechnologies (TSE:TH) Stock

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Receive TH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

TH Stock News Headlines

January 23, 2023 | marketwatch.com

HIV Market 2023 : Advance Technology, Latest Trend and Future Expansion by 2028

January 10, 2023 | marketwatch.com

Global HIV Antiretroviral Drug Market 2023 Size and Growth Analysis by Manufacture, Type, Application, Market Dynamic and Forecast to 2028

February 5, 2023 | Tradewins (Ad)

Know Your Profit Potential BEFORE You Trade!

I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now!

January 4, 2023 | finance.yahoo.com

Open Letter to Shareholders from CEO Paul Levesque

December 23, 2022 | finance.yahoo.com

Shareholders in Theratechnologies (TSE:TH) are in the red if they invested five years ago

December 1, 2022 | finance.yahoo.com

Theratechnologies Announces Update from Ongoing TH1902 Study

October 26, 2022 | finance.yahoo.com

Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays

October 13, 2022 | streetinsider.com

Form 6-K Theratechnologies Inc. For: Oct 13 - StreetInsider.com

February 5, 2023 | Tradewins (Ad)

Know Your Profit Potential BEFORE You Trade!

October 13, 2022 | investing.com

Theratechnologies Inc. Tops Q3 EPS by 4c By Investing.com - Investing.com

October 13, 2022 | benzinga.com

Theratechnologies: Q3 Earnings Insights - Theratechnologies (NASDAQ:THTX) - Benzinga

October 13, 2022 | globenewswire.com

Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update - GlobeNewswire

October 13, 2022 | finance.yahoo.com

Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update

October 12, 2022 | benzinga.com

Earnings Preview: Theratechnologies - Theratechnologies (NASDAQ:THTX) - Benzinga

October 12, 2022 | globenewswire.com

Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium - GlobeNewswire

October 12, 2022 | finance.yahoo.com

Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium

October 4, 2022 | nasdaq.com

Pre-market Movers: FNGR, AERC, FAZE, ARC, ADEA… - Nasdaq

October 4, 2022 | uk.investing.com

Why AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket By Benzinga - Investing.com UK

October 4, 2022 | seekingalpha.com

FaZe Holdings, KalVista Pharmaceuticals, Theratechnologies among premarket losers' pack - Seeking Alpha

October 3, 2022 | benzinga.com

Theratechnologies shares are trading higher after the company announced FDA approval of Trogarzo for admi - Benzinga

October 3, 2022 | benzinga.com

Theratechnologies' Trogarzo Approved By FDA For 30-Second Intravenous (IV) Push, Simplifying HIV Treatment For Heavily Treatment-Experienced Population - Theratechnologies (NASDAQ:THTX) - Benzinga

October 3, 2022 | finance.yahoo.com

Theratechnologies’ Trogarzo® Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment-Experienced Population

September 26, 2022 | finance.yahoo.com

Theratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update - Yahoo Finance

September 26, 2022 | finance.yahoo.com

Theratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update

September 12, 2022 | finance.yahoo.com

Theratechnologies TH1902 Study Published in Pharmaceutics Demonstrates Inhibition of Human Sortilin (SORT1)-Positive Ovarian and Triple-Negative Breast Cancer Stem-Like Cells and Tumor Growth

August 23, 2022 | marketwatch.com

HIV Market 2022, Gross Margin, Market Competitive Situation and Trends, Market Share of Top Players, Mergers and Acquisitions, Expansion by 2029

August 19, 2022 | seekingalpha.com

Theratechnologies (THTX) Investor Presentation - Slideshow

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive TH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

TH Company Calendar

Today: 2/05/2023
Next Earnings (Estimated): 2/23/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: TSE:TH
CUSIP: N/A
CIK: N/A
Web: www.theratech.com
Phone: +1-514-3367800
Fax: N/A
Employees: 87
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: C$3.25
High Stock Price Forecast: C$3.25
Low Stock Price Forecast: C$3.25
Forecasted Upside/Downside: +142.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: -8.5
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 562.07
Current Ratio: 1.05
Quick Ratio: 0.64

Sales & Book Value

Annual Sales: C$77.39 million
Price / Sales: 1.65
Cash Flow: C$0.36 per share
Price / Cash Flow: 3.76
Book Value: C($0.19) per share
Price / Book: -7.05

Miscellaneous

Outstanding Shares: 95,142,000
Free Float: N/A
Market Cap: C$127.49 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Paul Lévesque (Age 59)
Pres, CEO & Director
Comp: $1.24M

Mr. Philippe Dubuc M.B.A. (Age 56)
MBA, Sr. VP & CFO
Comp: $393.59k

Dr. Christian Marsolais Ph.D. (Age 60)
Sr. VP & Chief Medical Officer
Comp: $383.71k

Mr. John Leasure (Age 58)
Global Commercial Officer
Comp: $353.81k

Ms. Elif McDonald
Sr. Director of Investor Relations

Mr. Jocelyn Lafond L.L.M. (Age 55)
LL.B., Gen. Counsel & Corp. Sec.

Mr. Denis Boucher B.A. (Age 57)
L.L.B., VP of Communications & Corp. Affairs

Hon. Andre Dupras M.Sc. (Age 59)
VP of HR

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions

TH Stock - Frequently Asked Questions

Should I buy or sell Theratechnologies stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" TH shares.
View TH analyst ratings or view top-rated stocks.
What is Theratechnologies' stock price forecast for 2023?: 3 brokerages have issued 1-year target prices for Theratechnologies' stock. Their TH share price forecasts range from C$3.25 to C$3.25. On average, they expect the company's stock price to reach C$3.25 in the next twelve months. This suggests a possible upside of 142.5% from the stock's current price.
View analysts price targets for TH or view top-rated stocks among Wall Street analysts.
How have TH shares performed in 2023?: Theratechnologies' stock was trading at C$1.20 at the start of the year. Since then, TH stock has increased by 11.7% and is now trading at C$1.34.
View the best growth stocks for 2023 here.
When is Theratechnologies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our TH earnings forecast.

What other stocks do shareholders of Theratechnologies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Stars Group (TSGI), Theratechnologies (THERF), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Endeavour Mining (EDV), Nemaska Lithium (NMX), Shopify (SHOP), United Therapeutics (UTHR) and Avigilon (AVO).
What is Theratechnologies' stock symbol?: Theratechnologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TH."
How do I buy shares of Theratechnologies?: Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Theratechnologies' stock price today?: One share of TH stock can currently be purchased for approximately C$1.34.
How much money does Theratechnologies make?: Theratechnologies (TSE:TH) has a market capitalization of C$127.49 million and generates C$77.39 million in revenue each year.
How can I contact Theratechnologies?: Theratechnologies' mailing address is 2015 Peel St 5th Floor, MONTREAL, QC H3A 1T8, Canada. The official website for the company is www.theratech.com. The company can be reached via phone at +1-514-3367800.

This page (TSE:TH) was last updated on 2/5/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial